Macquarie Group LTD Illumina, Inc. Transaction History

Macquarie Group LTD

  • $87.4 Billion
  • Q1 2024

A detailed history of Macquarie Group LTD transactions in Illumina, Inc. stock. As of the latest transaction made, Macquarie Group LTD holds 473,972 shares of ILMN stock, worth $49.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
473,972
Previous 110,711 328.12%
Holding current value
$49.5 Million
Previous $15.4 Million 322.22%
% of portfolio
0.07%
Previous 0.02%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$127.73 - $147.2 $46.4 Million - $53.5 Million
363,261 Added 328.12%
473,972 $65.1 Million
Q4 2023

Feb 14, 2024
BUY
$92.79 - $142.53 $105,595 - $162,199
1,138 Added 1.04%
110,711 $15.4 Million
Q3 2023

Nov 14, 2023
BUY
$128.91 - $192.44 $228,041 - $340,426
1,769 Added 1.64%
109,573 $15 Million
Q2 2023

Aug 14, 2023
SELL
$183.43 - $232.67 $5,869 - $7,445
-32 Reduced 0.03%
107,804 $20.2 Million
Q1 2023

May 15, 2023
BUY
$193.75 - $232.55 $120,125 - $144,181
620 Added 0.58%
107,836 $25.1 Million
Q4 2022

Feb 21, 2023
BUY
$187.24 - $242.74 $167,579 - $217,252
895 Added 0.84%
107,216 $21.7 Million
Q3 2022

Nov 14, 2022
BUY
$177.23 - $227.44 $3.65 Million - $4.68 Million
20,582 Added 24.01%
106,321 $20.3 Million
Q2 2022

Aug 15, 2022
SELL
$181.58 - $368.0 $96,600 - $195,776
-532 Reduced 0.62%
85,739 $15.8 Million
Q1 2022

May 16, 2022
BUY
$303.87 - $423.8 $217,267 - $303,017
715 Added 0.84%
86,271 $30.1 Million
Q4 2021

Feb 11, 2022
SELL
$347.28 - $421.83 $583,777 - $709,096
-1,681 Reduced 1.93%
85,556 $32.5 Million
Q3 2021

Nov 12, 2021
SELL
$405.61 - $524.84 $664,389 - $859,687
-1,638 Reduced 1.84%
87,237 $35.4 Million
Q2 2021

Aug 13, 2021
BUY
$372.84 - $481.5 $1.83 Million - $2.36 Million
4,904 Added 5.84%
88,875 $42.1 Million
Q1 2021

May 14, 2021
SELL
$361.28 - $504.76 $109 Million - $152 Million
-301,889 Reduced 78.24%
83,971 $32.3 Million
Q4 2020

Feb 16, 2021
SELL
$292.7 - $370.96 $5.57 Million - $7.06 Million
-19,036 Reduced 4.7%
385,860 $143 Million
Q3 2020

Nov 13, 2020
BUY
$268.51 - $400.74 $20 Million - $29.9 Million
74,545 Added 22.57%
404,896 $125 Million
Q2 2020

Aug 11, 2020
SELL
$256.46 - $373.01 $5.72 Million - $8.32 Million
-22,303 Reduced 6.32%
330,351 $122 Million
Q1 2020

May 15, 2020
SELL
$209.2 - $335.53 $8.47 Million - $13.6 Million
-40,480 Reduced 10.3%
352,654 $96.3 Million
Q4 2019

Feb 14, 2020
SELL
$288.29 - $335.49 $19.1 Million - $22.3 Million
-66,384 Reduced 14.45%
393,134 $130 Million
Q3 2019

Nov 14, 2019
BUY
$266.84 - $378.23 $45.2 Million - $64 Million
169,228 Added 58.3%
459,518 $140 Million
Q2 2019

Aug 14, 2019
SELL
$300.59 - $368.15 $4.87 Million - $5.97 Million
-16,212 Reduced 5.29%
290,290 $107 Million
Q1 2019

May 15, 2019
SELL
$272.57 - $321.18 $20.8 Million - $24.5 Million
-76,230 Reduced 19.92%
306,502 $95.2 Million
Q4 2018

Feb 15, 2019
SELL
$272.46 - $366.54 $11.7 Million - $15.7 Million
-42,875 Reduced 10.07%
382,732 $115 Million
Q3 2018

Nov 15, 2018
BUY
$279.04 - $367.06 $11.2 Million - $14.8 Million
40,228 Added 10.44%
425,607 $156 Million
Q2 2018

Aug 14, 2018
SELL
$228.17 - $292.07 $3.5 Million - $4.49 Million
-15,358 Reduced 3.83%
385,379 $108 Million
Q1 2018

May 11, 2018
BUY
$209.54 - $253.91 $23.8 Million - $28.8 Million
113,473 Added 39.5%
400,737 $94.7 Million
Q4 2017

Feb 15, 2018
BUY
$202.23 - $230.03 $48.1 Million - $54.8 Million
238,046 Added 483.66%
287,264 $62.7 Million
Q3 2017

Nov 08, 2017
BUY
$172.3 - $213.93 $8.48 Million - $10.5 Million
49,218
49,218 $9.81 Million

Others Institutions Holding ILMN

# of Institutions
875
Shares Held
139M
Call Options Held
1.09M
Put Options Held
1.91M
View Full List

About ILLUMINA, INC.

ILMN Quotes by TradingView
  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $16.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email